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Non-ribosomal peptide synthetases (NRPSs) 
are large, multi-domain proteins that are 
involved in the biosynthesis of an array of 
secondary metabolites. We report the 
structure of the third adenylation domain 
from the siderophore-synthesizing NRPS, 
SidN, from the endophytic fungus, 
Neotyphodium lolii. This is the first 
structure of a eukaryotic NRPS domain and 
it reveals a large binding pocket required to 
accommodate the unusual amino acid 
substrate, Nδ-cis-anhydromevalonyl-Nδ-
hydroxy-L-ornithine (cis-AMHO). The 
specific activation of cis-AMHO was 
confirmed biochemically and an AMHO 
moiety was unambiguously identified as a 
component of the fungal siderophore using 
mass spectroscopy. The protein structure 
shows that the substrate-binding pocket is 
defined by 17 amino acid residues, in 
contrast to both prokaryotic adenylation 
domains and to previous predictions based 
on modeling. Existing substrate prediction 
methods for NRPS adenylation domains fail 
for domains from eukaryotes due to the 
divergence of their signature sequences 
from those of prokaryotes. Thus, this new 
structure will provide a basis for improving 
prediction methods for eukaryotic NRPS 
enzymes which play important and diverse 
roles in the biology of fungi.  
 
The non-ribosomal peptide synthetases 
(NRPSs)4 are large, multimodular enzymes, 
which are ubiquitous in both bacteria and 
fungi. These enzymes are involved in the 
synthesis of a wide array of secondary 
metabolites which have diverse biological 
roles including iron sequestration, anti-
microbial, anti-insecticidal, and antiviral 
activity (1,2). These compounds have had a 
very significant impact on human health since 
the discovery and development of penicillin 
by Fleming, Florey and Chain in the 1920s 
and 1930s and they are currently used as 
antibiotics, antivirals, immunosuppressants 
and antitumor agents in humans. NRPSs 
synthesize peptides by a multiple carrier 
thiotemplate mechanism similar to that 
employed by polyketide synthases and fatty 
acid synthases (1,3). In general, NRPSs are 
modular, with each module catalyzing the 
incorporation of one amino acid substrate into 
the growing peptide. NRPS modules are, in 
turn, made up of independently-folding 
functional domains that catalyze the individual 
reactions of peptide synthesis. The adenylation 
domain selects and activates the amino acid 
substrate before attaching it to a 
4’-phosphopantetheine (4’ppant) prosthetic 
group on the adjacent peptide carrier protein 
(PCP) domain.  
 
NRPS adenylation domains are members of 
the acetyl-CoA synthetase-like superfamily (as 
defined by SCOP (4)). The corresponding 
Pfam family (PF00501) (5) contains over 
17,000 sequences from ~1550 different 
species including bacteria, archaea and 
eukarya. Despite low sequence similarity, this 
superfamily shows a high degree of structural 
and functional conservation (6). Members of 
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the superfamily activate carboxylic acids by 
an adenylation reaction, utilizing ATP and 
forming an enzyme-bound adenylate 
intermediate. In most cases, these enzymes 
subsequently catalyze the formation of a 
thioester bond to either a CoA molecule or a 
4’ppant prosthetic group. Members of the 
superfamily play roles in the biosynthesis and 
degradation of an array of important primary 
and secondary metabolites. Different members 
of the superfamily activate diverse substrates 
ranging from very small carboxylic acids such 
as acetate (7) to very large substrates such as 
2-amino-9,10-epoxy-8-oxodecanoic acid (8). 
Thus, the architecture of the binding pocket 
used to achieve substrate-specificity by 
individual family members is of significant 
interest. 
 
Following the publication of the first structure 
of an NRPS adenylation domain, PheA (the 
phenylalanine-activating adenylation domain 
from GrsA, the gramicidin S NRPS from 
Bacillus brevis (9)), a number of methods for 
predicting the specificity of NRPS adenylation 
domains have been developed based on the 
similarity of the binding pocket residues to 
those of previously-characterized domains 
with known specificity (10-12). These 
methods work well for predicting the 
substrates for adenylation domains from 
prokaryotic NRPSs but are less successful for 
both eukaryotic NRPSs (13-15) and 
prokaryotic domains that activate unusual 
substrates. The three known structures of 
NRPS adenylation domains (9,16,17) are all of 
prokaryotic origin (as are all current NRPS 
domain structures). Furthermore, the 
previously determined structures of members 
of the acetyl-CoA synthetase-like superfamily 
bind and activate small- and medium-sized 
substrates and it is expected that the binding 
pockets for larger substrates are substantially 
different (13,18).  
 
Amongst the largest substrates of the acetyl-
CoA synthetase-like superfamily are the 
Nδ-acyl-Nδ-hydroxyornithines (AHOs) found 
in the NRPS-synthesized fungal hydroxamate 
siderophores. These siderophores chelate iron 
through the bidentate hydroxamate group of 
the AHOs (19). One class of fungal 
hydroxamate siderophore are the ferrichromes, 
which are made up of three AHO residues and, 
in most cases, three other proteogenic amino 
acids (19). The particular acyl group of the 
AHOs differ between various ferrichromes 
that have been identified and characterized 
(19). 
 
A novel NRPS gene, sidN, from the 
Epichloë/Neotyphodium complex (phylum 
Ascomycota, family Clavicipitaceae) of grass 
endophytes has recently been cloned and 
characterized5. The NRPS encoded by sidN is 
a siderophore synthetase with a three-module 
organization which resembles previously 
characterized NRPSs (13,20) that synthesize 
ferrichromes. The mutualistic relationship 
between the fungal endophytes of the 
Epichloë/Neotyphodium complex and the 
agronomic grasses that they colonize plays a 
vital role in the pastoral agriculture of many 
parts of the world by improving the grass 
plants’ tolerance to abiotic and biotic stresses 
(21,22). SidN is essential for the maintenance 
of the mutualistic character of this relationship 
and the details of the cloning and 
characterization of sidN will be reported 
elsewhere6.  
 
Recently, attempts have been made to predict 
the specificities of the adenylation domains of 
siderophore synthetases using methods such as 
homology modeling and inspection of the 
predicted substrate binding pocket residues 
(13,18). These studies have predicted that the 
third adenylation domain of the three-module 
siderophore synthetases bind and activate the 
AHO residues and that these domains have a 
larger binding pocket than has previously been 
characterized (13,18). However, experimental 
confirmation of these predictions has been 
hampered by technical difficulties in 
producing soluble protein of eukaryotic 
adenylation domains in heterologous 
expression systems (13). 
 
We have expressed, purified and determined 
the three-dimensional structure of the third 
adenylation domain of SidN (SidNA3) from 
Neotyphodium lolii Lp19 at 2.0 Å resolution. 
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We have also biochemically characterized this 
domain, confirming that SidNA3 adenylates 
the large non-proteogenic amino acid, 
Nδ-cis-anhydromevalonyl-Nδ-hydroxy-
L-ornithine (cis-AMHO). In addition, this 
amino acid has been confirmed as a 
component of the fungal siderophore using 
mass spectroscopy. This is the first structure 
of a eukaryotic NRPS domain reported and 
thus provides details of the architecture of the 
specificity-determining pocket for eukaryotic 
adenylation domains. The structure and 
biochemistry of SidNA3 also extends our 
knowledge of the large acetyl-CoA synthetase-
like superfamily for which there are only a 
handful of structures despite their diversity 
and ubiquity in nature.  
 
EXPERIMENTAL PROCEDURES 
 
Protein expression and purification—The 
SidNA3 domain was amplified from 
Neotyphodium lolii Lp19 genomic DNA and 
cloned using the Gateway® system 
(Invitrogen) into the pDest17 expression 
vector (Invitrogen). A two-step nested PCR 
protocol was used to introduce the sequence 
for a recombinant Tobacco Etch Virus (rTEV) 
protease cleavage site into the PCR product to 
enable removal of the poly-histidine fusion tag 
(23). The plasmid was transformed into 
Escherichia coli Rosetta™ (DE3) cells by 
electroporation. Expression was performed at 
18 °C in ZYP-5052 autoinduction medium 
(24). The expressed protein (in 25 mM sodium 
phosphate pH 6.5, 500 mM NaCl, 10 mM 
imidazole, 5 mM βMe) was purified by 
immobilized metal affinity chromatography 
(IMAC). The poly-histidine fusion tag was 
removed by digestion with rTEV protease. 
The cleaved SidNA3 protein was purified by 
subtraction IMAC and then further purified by 
size exclusion chromatography using a 
HiLoad™ 16/60 Superdex™ 75 pg column 
(GE Healthcare) with 25 mM MES pH 6.5, 
500 mM NaCl, 5 mM βMe as the running 
buffer. Seleno-methionine substituted protein 
was prepared by the same protocol except that 
PASM-5052 medium (24) was used as the 
expression medium. 
 
Mass spectrometry of the SidN siderophore—
A liquid culture of Epichloë festucae strain Fl1 
was grown for approximately 2 weeks at 22 ºC 
in modified Mantle media (25), with yeast 
extract replaced with 0.6 µM thymine. The 
supernatant was separated by centrifugation 
and freeze-dried, and 50 g of the dried 
material was extracted with methanol 
(500 mL).  The extract was evaporated to 
dryness under reduced pressure, reconstituted 
in MilliQ water (200 mL) and eluted through a 
solid-phase extraction cartridge (1 g, Isolute 
ENV+, International Sorbent Technology).  
The cartridge was washed with water (10 mL), 
and a siderophore fraction eluted with 
methanol (10 mL).  The fraction was 
evaporated to dryness and stored at 0 ºC, and 
reconstituted in 1:1 acetonitrile:water with 
0.1% formic acid for infusion into an LTQ FT 
mass spectrometer (Thermo Fisher Scientific) 
using static nanospray ESI in +ve mode.  The 
spray voltage was 5.0 kV and the capillary 
temperature 225 °C.  HRESIMS (m/z, rel int 
(%)), [MH]+ 1083.53405 (calcd. for 
C46H75N12O18, 1083.53168); ms2 1083.5 @ cid 
60: 1065.52547 (100) (calcd. for 
C46H73N12O17, 1065.52111), 971.48365 (30) 
(calcd. for C40H67N12O16, 971.47925), 
953.45933 (58) (calcd. for C41H65N10O16, 
953.45745), 841.40907 (35) (calcd. for 
C35H57N10O14, 841.40502). 
 
Nδ-cis-anhydromevalonyl-Nδ-hydroxy-
L-ornithine purification—cis-AMHO was 
obtained by alkaline hydrolysis of fusigen (26) 
(EMC microcollections). A solution of fusigen 
was adjusted to pH 12.0 using 1 N NaOH and 
incubated at room temperature for 1 h 
followed by overnight incubation at 4 °C. The 
solution was neutralized with 1 N HCl. The 
resulting cis-AMHO was purified by HPLC 
using a Luna 3 µ C18(2) 100 Å  150x3 mm 
column (Phenomenex) and a water:acetonitrile 
gradient (no ion-pairing agent) of 0-22% over 
20 mins using a 0.3 mL min-1 flow rate. 
Separation was performed on a System Gold 
instrument (Beckman Coulter) and detection 
was via absorbance at 220 nm. The cis-
AMHO had a retention time of ~13 mins. The 
cis-AMHO was dried using a Vacufuge 
Concentrator 5301 (Eppendorf) to remove the 
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acetonitrile and redissolved to the required 
concentration in water prior to use. 
 
Inorganic pyrophosphate release assay—The 
release of inorganic pyrophosphate was 
assayed using an EnzChek® pyrophosphate 
assay kit (27) (Invitrogen). The assays were 
carried out at 30 °C in 100 µL volumes in a 
96-well microtiter plate. Each reaction 
contained 50 mM Tris-HCl (pH 7.5), 10 mM 
MgCl2, 1 mM ATP, 0.25 mM 2-amino-
6-mercapto-7-methylpurine ribonucleoside 
(MESG), 1 unit purine nucleoside 
phosphorylase, and 0.03 units inorganic 
pyrophosphatase, 1 µM SidNA3, 0.2 mM 
amino acid substrate. Following a 20-min 
incubation to remove contaminating 
pyrophosphate and phosphate, the reaction 
was initiated by addition of the amino acid 
substrate. The 360 nm absorbance was 
monitored using an EnVision® 2104 multilabel 
plate reader (Perkin-Elmer), reading every 2 ½ 
 mins. The initial rates for steady-state kinetics 
were measured using the same method except 
that 0.4 mM MESG and 2 mM ATP were used 
together with varying amounts of the amino 
acid substrate, cis-AMHO. For the steady-state 
kinetics measurements, two replicates were 
performed for each concentration and 
absorbance readings were made every 10 sec. 
 
Crystallization—Crystallization was per-
formed using the sitting drop vapor diffusion 
method at 18 °C. Initial crystallization trials 
were conducted with drops consisting of 
100 nL each of protein (8 mg/mL in 25 mM 
MES pH 6.5, 200 mM NaCl, 5 mM βMe, 
1 mM MgCl2, 2 mM ATP and 5 mM CoA) 
and precipitant solutions. The initial crystals 
grew in 25.5% PEG 4000, 0.17 M ammonium 
sulphate, and 15% glycerol. Extensive 
optimization of the crystallization conditions 
and micro-seeding resulted in diffraction-
quality crystals with the best crystals growing 
in 0.1 M MES pH 6.5, 13-14% PEG 4000, 
0.01-0.02 M ammonium sulphate, and 15% 
glycerol using protein at 5 mg mL-1 in 25 mM 
MES pH 6.5, 200 mM NaCl, 5 mM βMe, 
1 mM MgCl2, and 2-5 mM CoA. The 
crystallization behavior of the seleno-
methionine substituted protein was identical to 
that of native protein. 
 
Structure determination—Data collection was 
performed on flash-cooled crystals at the 
Stanford Synchrotron Radiation Laboratory, 
Stanford University, USA. One high-
resolution dataset and one multiple 
wavelength anomalous dispersion (MAD) 
dataset from seleno-methionine substituted 
protein crystals were collected and used for 
structure determination. The data was 
processed with MOSFLM (28) and SCALA 
(29). AutoSharp (30) was used to determine 
phase information from MAD. Nineteen 
seleno-methionine sites were found with a 
figure of merit for phasing of 0.37. There were 
two molecules per asymmetric unit but density 
was only present for one of the two C-terminal 
domains.  
 
Automatic model building was carried out 
using RESOLVE (31) through the PHENIX 
AutoBuild wizard (32) followed by manual 
building in Coot (33) and refinement using 
phenix.refine (34). The high-resolution dataset 
and experimental phases from the MAD 
dataset were used. Restrained individual 
coordinates, restrained isotropic B factors and 
TLS parameters were refined with non-
crystallographic symmetry (NCS) restraints 
applied to the N-terminal domains. For the 
TLS refinement, three TLS groups consisting 
of each of the two N-terminal domains and the 
ordered C-terminal domain were defined.  
 
The final model included a total of 903 
residues out of the expected 1124 residues per 
asymmetric unit (of the missing 221 residues, 
136 were from the missing C-terminal 
domain). Chain A (N-terminal domain only) 
consisted of residues 13-40, 46-179, and 183-
421 while Chain B (N-terminal and C-terminal 
domains) consisted of residues 12-40, 46-180, 
183-426, 430-456, 465-482, and 487-535. The 
single C-terminal domain that was modeled 
appears to be mobile with weak density and a 
high average B factor of 77.9 Å2 compared to 
30.9 Å2 for the N-terminal domain in the same 
molecule (Chain B). In the final model, 96.2% 
of the residues lie in favoured regions, and 
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3.6% of the residues lie within allowed 
regions of the Ramachandran plot. There is 
just one Ramachandran outlier in each chain, 
which is Gly322. This residue lies at the 
entrance to the amino acid binding pocket. 
Data collection and refinement statistics are 
given in Table 1.  
 
Ligand docking—The energy-minimized AHO 
models were constructed using ChemBio3D 
Ultra (CambridgeSoft). Using GOLD (35), the 
ligand was docked into an area of the SidNA3 
structure with a radius of 7-8 Å centered on 
the binding pocket and using the ‘Detect 
Cavity’ option. The ‘Standard default settings’ 
genetic algorithm parameters and the default 
parameters of the ChemScore (36) scoring 
function were used. Ten docking runs were 
performed for each ligand model and the top 
three solutions were kept. 
 
RESULTS 
 
SidNA3 expression and purification—
Successful expression and purification of the 
third adenylation domain of SidN (SidNA3) 
was achieved by making a range of constructs 
which were tested for soluble protein 
expression. Optimization of the N- and C-
terminal borders of the domain was of 
particular importance as differences of just 14 
amino acids at either end of the construct lead 
to either soluble or insoluble protein 
expression (37). Initially, longer constructs of 
the SidNA3 domain exhibited a strong 
tendency to form large soluble aggregates, as 
determined by size exclusion chromatography. 
Subsequent optimization of the construct 
borders and of the purification and storage 
buffer conditions yielded protein which was 
suitable for biochemical characterization and 
crystallization. The final 61 kDa SidNA3 
protein domain was comprised of residues 
2270-2826 of SidN.  
 
The product of SidN—Evidence that SidN 
incorporates AMHO residues was provided by 
mass spectrometric examination of the 
siderophore produced by SidN from Epichlöe 
festucae Fl1. For these studies Epichlöe 
festucae Fl1 was used as a model organism for 
producing the siderophore after mass 
spectroscopy showed that the siderophores 
produced by sidN from N. lolii Lp19 and E. 
festucae Fl1 are identical7. Further, a 
comparison of the amino acid sequence of the 
SidNA3 domain from E. festucae Fl1 shows 
99% identity to that from N. lolii Lp19. A 
siderophore rich fraction was obtained from an 
extract of the supernatant of an E. festucae Fl1 
culture grown under iron-depleted conditions 
using solid phase extraction (38). The fraction 
was examined by high resolution Fourier 
transform mass spectrometry on a hybrid ion-
trap ion cyclotron mass spectrometer.  On 
infusion into the ESI source an ion of m/z 
1083.53405 ([MH]+, C46H75N12O18, calculated 
mass 1083.53168) was observed. This ion was 
not detected in samples from cultures of 
E. festucae Fl1 in which the sidN gene had 
been knocked out by gene replacement8. 
Collision-induced dissociation of this species 
in the ion-trap spectrometer gave major 
product ions from neutral losses of 112.05040 
(anhydromevalonyl moiety, C6H8O2, 
calculated mass 112.05188), 130.07472 
(hydroxyornithyl moiety, C5H10N2O2, 
calculated mass 130.07368) and 242.12498 
(AMHO moiety, C11H18N2O4, calculated mass 
242.12611), and water. These results show 
that the acyl group of the three AHO residues 
in the SidN-produced siderophore is 
anhydromevalonyl. The anhydromevalonyl 
group can exist as either the cis or trans 
isomer but the mass spectrometry results do 
not provide any information on which isomer 
is present in the SidN siderophore. Further 
work to fully characterize the siderophore, 
using high-resolution NMR, is currently 
underway. 
 
SidNA3 activates Nδ-cis-anhydromevalonyl-
Nδ-hydroxy-L-ornithine—Previous studies 
have predicted that the third adenylation 
domain of the three-module siderophore 
synthetases adenylate the AHO residues 
(13,18). In order to confirm this prediction, a 
continuous spectroscopic assay (27) that 
measures the release of inorganic 
pyrophosphate by the adenylation reaction was 
employed to investigate the substrate 
specificity of the SidNA3 domain. cis-AMHO 
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was obtained by hydrolysis of the siderophore 
fusigen (26), a cyclic trimer of cis-AMHO 
monomers connected by head-to-tail ester 
bonds. The activity assays showed that 
SidNA3 specifically adenylates cis-AMHO 
but did not adenylate L-ornithine or any of the 
20 proteogenic amino acids (Fig. 1). We were 
unable to source trans-AMHO, and thus could 
not investigate whether SidNA3 shows any 
preference for the cis or trans isomer of the 
anhydromevalonyl group.  By monitoring the 
steady-state kinetics of pyrophosphate release 
via this assay, we determined the observed Km 
and kcat values for adenylation of cis-AMHO 
to be 40.0 ±5.0 µM and 0.92 ±0.04 min-1, 
respectively. The two auxiliary enzymes used 
in this enzyme-coupled assay were present in 
excess and have reported rates which suggest 
that the adenylation reaction was rate limiting. 
Thus, the observed Km and kcat values seen 
here are likely to reflect the adenylation step 
catalyzed by SidNA3. This Km value for cis-
AMHO and SidNA3 is of the same order of 
magnitude as the Km values previously 
determined for other NRPS adenylation 
domains and their cognate amino acid 
substrates (39,40). The low kcat value is the 
result of the slow catalytic turnover due to 
slow release of the enzyme-bound adenylate. 
It is likely that this rate would be greatly 
enhanced in the presence of the flanking 
domains of the NRPS, as the 4’ppant 
prosthetic group on the adjacent PCP domain 
would immediately react with the adenylated 
amino acid.  
 
The structure of SidNA3—SidNA3 was 
crystallized by the sitting drop method in the 
presence of CoA. The structure of SidNA3 
was determined by multiple wavelength 
anomalous dispersion (MAD) using SeMet-
substituted protein. SidNA3 has two domains 
(Fig. 2), an N-terminal domain (residues 12-
421) and a smaller C-terminal domain 
(residues 422-535) (numbering for SidNA3 
used here begins with the first native residue 
in the expression construct; Fig. 3). The 
N-terminal domain is made up of a distorted 
six-stranded antiparallel β-barrel together with 
an αβαβα structure formed by two 
predominantly parallel β-sheets (seven- and 
eight-stranded) flanked by α-helices. The core 
of the C-terminal domain is made up of a 
three-stranded antiparallel β-sheet surrounded 
by three α-helices. A long loop in the 
C-terminal domain, located between the final 
β-strand and the final α-helix, loops back 
towards the N-terminal domain (Fig. 2). The 
secondary and tertiary structures for each 
domain are very similar to that of PheA (9), 
with rmsd values of 1.6 Å for the N-terminal 
domain (369 residues aligned) and 1.4 Å for 
the C-terminal domain (79 residues aligned). 
Nevertheless, SidNA3 does show some 
significant differences to the acetyl-CoA 
synthetase-like superfamily. SidNA3 lacks 
three α-helices that are found in PheA and, in 
turn, has an additional two α-helices (Fig. 3). 
One of the three absent α-helices is at the 
N-terminus and some of the residues that 
would be expected to form this α-helix were 
not included in the SidNA3 construct that was 
used (Fig. 3). Hence, it is not clear whether 
this α-helix is present in the native SidNA3 
domain. However, the remaining two absent 
α-helices and one of the two additional α-
helices are within the N-terminal domain and 
are associated with insertions and deletions in 
the sequence (Fig. 3). The final additional α-
helix in SidNA3 is at the C-terminus. Apart 
from PheA, this C-terminal α-helix is present 
in all of the structures of members of the 
acetyl-CoA synthetase-like superfamily that 
contain this region of the protein.  
 
SidNA3 is in an “open” conformation—Most 
members of the acetyl-CoA synthetase-like 
superfamily are thought to adopt two distinct 
conformations in order to catalyze the two 
reactions that are performed by these enzymes 
– the adenylation and thiolation reactions 
(7,41). Previous structures show the two 
conformations differ by an ~140° rotation of 
the C-terminal domain relative to the 
N-terminal domain. SidNA3 was crystallized 
in a third conformation where the C-terminal 
domain is rotated ~45° relative to the 
orientation seen in the adenylation 
conformation (Fig. 4A). We describe this as an 
“open” conformation as there is a wide 
separation between the C-terminal and N-
terminal domains of SidNA3. There are very 
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few interactions between the two domains or 
between the C-terminal domain and 
neighboring molecules in the crystal. The 
accessibility of the active site, located between 
the two domains at the surface of the 
N-terminal domain, is much greater in the 
open conformation of SidNA3 compared to 
the adenylation conformation seen in some 
other structures, such as that of PheA (Fig. 
4B).  
 
As would be expected from the lack of 
molecular interactions between the domains, 
the C-terminal domain of SidNA3 is not held 
rigidly in the open conformation and is 
probably quite mobile, reflected in a high 
average B factor (77.9 Å2) compared to the 
N-terminal domain in the same molecule (30.9 
Å2) and has weaker electron density. Electron 
density is not present for many sidechains of 
residues in this C-terminal domain and there is 
no density for several other residues (residues 
427-429, 457-464, 483-486, 536-557). Further 
support for C-terminal domain mobility is the 
complete absence of electron density for the 
C-terminal domain for the second of the two 
molecules in the asymmetric unit. 
Significantly, this missing C-terminal domain 
cannot occupy the same orientation as the 
ordered C-terminal domain of the other 
monomer as this would cause clashes with 
neighboring molecules in the crystal. 
Similarly, it cannot occupy the adenylation or 
thiolation conformations previously reported 
due to the geometry of crystal packing. The 
missing C-terminal domain is not the result of 
degradation of the protein as demonstrated by 
SDS-PAGE and mass spectroscopy (data not 
shown). The positional disorder of the 
C-terminal domain makes sense in light of the 
lack of interactions between the two domains 
in the open conformation. Similar open 
conformations with a wide separation between 
the two domains have been observed in four 
other members of the superfamily (PDB 
codes: 1lci (42), 1ult (43), 2vsq (17), and 
3g7s). The orientation of the two domains is 
different in each of these structures. It is likely 
that the individual crystal packing 
arrangements stabilize the exact orientation 
seen in each of these structures, and that the 
C-terminal domains are all significantly 
mobile in solution.  
 
Architecture of the SidNA3 active site and 
substrate-binding pocket—The ATP- and 
amino acid-binding pockets of the active site 
were identified by comparison to PheA (9). 
The ATP-binding channel and the amino-acid 
binding pocket are adjacent to each other on 
the face of the N-terminal domain between it, 
and the C-terminal domain. The ATP-binding 
pocket of SidNA3 shows the archetypal 
conserved motif 178TSGSTGTPK186, which is 
similar to the P-loop seen in many ATP-
binding proteins (44). This loop is thought to 
be flexible and has been observed in many 
conformations in the structures of acetyl-CoA 
synthetase-like superfamily members. In 
SidNA3 there is also evidence for flexibility 
insofar as three amino acids are missing due to 
poor electron density (Gly180, Ser181 and 
Thr182). 
 
The amino acid-binding pocket of SidNA3 is 
much larger than that of PheA (Fig. 5), 
consistent with it binding the large amino acid 
substrate, AMHO. In contrast to PheA, the 
SidNA3 pocket is defined by the main-chain 
and sidechains of seventeen residues (Phe198, 
Trp202, Ile206, Phe222, Asp231, Val232, 
Gly235, Glu236, Leu239, Gly272, Tyr293, 
Gly295, Val296, Gly297, Val320, Ile328 and 
Gly329). These overlap with the equivalent 
nine residues that line the PheA substrate-
binding pocket along with eight additional 
residues (Phe198, Trp202, Ile206, Phe222, 
Glu236, Leu239, Tyr293, and Val296) which 
lie deeper in the interior of the N-terminal 
domain where they bind the hydrophobic 
anhydromevalonyl moiety. The larger size of 
the binding pocket in SidNA3 when compared 
to PheA is the result of the substitution of a 
tryptophan residue that defines the bottom of 
the binding pocket (Trp239 in PheA) with a 
glycine residue (Gly235 in SidNA3) (Fig. 5B). 
There are five glycines in total lining the 
SidNA3 pocket, giving a large hydrophobic 
cavity containing only a few potential 
hydrogen bonding groups. 
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Previous homology modeling had predicted 
that the AHO-adenylating domains of three-
module siderophore synthetases would have 
larger pockets than PheA (13,18), however the 
observed architecture of the SidNA3 pocket 
differs from that predicted. Schwecke et al. 
(13) predicted that the binding pockets of 
AHO-adenylating domains would be lined by 
three extra residues, beyond the nine seen in 
the PheA. One of the three predicted extra 
residues is seen to line the binding pocket of 
SidNA3 (Phe222). Similarly, Bushley et al. 
(18) predicted that seven residues, in addition 
to the nine seen in PheA, had the potential to 
contribute to the pocket of AHO-adenylating 
domains. For SidNA3 two of these predicted 
residues (Glu236 and Leu239) were observed 
to be lining the pocket. Thus, the experimental 
determination of the SidNA3 structure 
provides a new template to advance our 
understanding of the determinants of substrate 
binding in NRPSs that adenylate large amino 
acids, and in particular, those that synthesize 
hydroxamate siderophores. 
 
The open conformation of SidNA3 has 
implications for substrate binding—In PheA, 
the α-amino and α-carboxylate groups of the 
phenylalanine ligand are held in place by 
interactions with Asp235 and Lys517 (which 
is also involved in binding ATP) (9) (Fig. 5C). 
The equivalent residue to Asp235 in SidNA3, 
Asp231, is in an almost identical position (Fig. 
5C). However, Lys517, and its equivalent in 
SidNA3, Lys526, are located on a loop that 
extends from the C-terminal domain into the 
active site. Due to the different C-terminal 
domain orientation in the SidNA3 structure, 
Lys526 is shifted ~11 Å from the equivalent 
position of Lys517 in the PheA structure. 
Another consequence of the difference in the 
position of the C-terminal domain loop is that 
in the SidNA3 structure, the sidechain of the 
conserved aromatic residue Phe230 is in a 
different conformation to that of the 
equivalent residue in PheA, Phe234. In PheA 
(9), the C-terminal domain loop restricts the 
rotation of the side chain of Phe234, ensuring 
that it points towards the amino acid binding 
pocket where it forms a binding surface for the 
main-chain atoms of the phenylalanine ligand, 
restricting their movement (Fig. 5C). In 
contrast, in the SidNA3 structure this surface 
does not exist as the orientation of the 
C-terminal domain loop allows the Phe230 
sidechain to point away from the amino acid 
binding pocket, opening up the mouth of the 
pocket (Fig. 5C). In order to correctly bind the 
amino acid ligand, a conformational change 
from the open conformation to the adenylation 
conformation would be required to move the 
C-terminal domain loop into a position such 
that Phe230 and Lys526 can take on their roles 
in ligand binding. 
 
Ligand docking of Nδ-acyl-Nδ-hydroxy-
ornithines—In order to gain insight into the 
binding specificity of SidNA3, we conducted 
in silico ligand docking with the SidNA3 
structure, using a library of AHOs containing 
the eight acyl groups that have been observed 
in siderophores (Fig. 6). Each stereoisomer 
was modeled separately, resulting in a library 
of 32 compounds. The ligand docking was 
carried out with GOLD (35) and binding poses 
were assessed using the ChemScore (36) 
scoring function. Consistent with SidNA3 
being an AMHO-adenylating domain, the top-
ranked ligand from the docking run was 
Nδ-cis-anhydromevalonyl-Nδ-hydroxy-
L-ornithine (cis-AMHO), with Nδ-cis-
anhydromevalonyl-Nδ-hydroxy-D-ornithine 
ranked second (Table 2). Visualization of the 
binding poses of the top three solutions for the 
cis-AMHO ligand showed that the ligand is 
placed in an extended conformation in the 
binding pocket with all three solutions being 
well clustered with an rmsd value of 0.34 Å 
(Fig. 5D). All of the top ten-ranked ligands 
except Nδ-cis-5-acetoxy-3-methylpent-2-
enoyl-Nδ-hydroxy-D-ornithine showed an 
identical hydrogen bonding pattern. The 
terminal hydroxy group of the ligand 
hydrogen bonds to the sidechain hydroxyl of 
Tyr293 and the Nδ-hydroxy of the 
hydroxamate group hydrogen bonds to the 
main-chain carbonyl oxygen of Ile328 (Fig. 
5D). In contrast, the likely hydrogen bond to 
the carbonyl oxygen of the hydroxamate group 
remains unsatisfied in all of the docking 
solutions, which would be energetically 
unfavorable. The hydroxamate group is able to 
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adopt either the synperiplanar (sp) or 
antiperiplanar (ap) conformations (45). This 
group was allowed to flip during the GOLD 
docking with the ligand adopting the ap 
conformation in the top-ranked GOLD 
solutions. In any case, there are no obvious 
hydrogen bonding partners in the binding 
pocket for either ligand conformation. 
However, the pocket is very wide at this point 
and it is possible that a water molecule could 
be involved in satisfying the hydrogen 
bonding potential of this carbonyl oxygen and 
bridging between the ligand and main-chain 
atoms. Despite extensive crystallization 
experiments, we have been unable to 
determine a structure of SidNA3 with cis-
AMHO in the binding pocket. 
 
Comparison of the binding pockets of other 
siderophore synthetases—To further 
investigate the binding of AHOs to the 
adenylation domains of siderophore 
synthetases, we compared the pocket-lining 
residues of a range of domains that adenylate 
these substrates. AHO-adenylating domains 
from other fungal siderophore synthetases 
were identified by searching the relevant 
literature. A multiple sequence alignment 
containing SidNA3 and these domains was 
produced using T-Coffee (46) and fifteen 
residues predicted to line the pocket for these 
adenylation domains were extracted from the 
multiple sequence alignment (Table 3). These 
putative pocket-lining residues were the 
equivalents of those lining the SidNA3 pocket 
apart from Asp231 (invariant in adenylation 
domains) and Val296 (only main-chain atoms 
lining the pocket). The domains that adenylate 
ligands with cis-anhydromevalonyl as the acyl 
group form a distinct cluster (including, as 
expected, SidNA3), as do six of the domains 
that activate ligands with acetyl as the acyl 
group (Table 3).  
 
The common binding pocket architectures of 
the acetyl-CoA synthetase-like superfamily—
The structures of eighteen other members of 
the acetyl-CoA synthetase-like superfamily 
are available. In order to gain insight into the 
common architecture of the binding pockets of 
the superfamily, we compared the pockets of 
these structures with each other and SidNA3 
(Table 4). Three of the structures – the long-
chain fatty acyl-CoA synthetase (LCFA) from 
Thermus thermophilus (43) and the luciferase 
(Luci) enzymes from the Japanese (47) and 
American (42) fireflies – have larger binding 
pockets than SidNA3 (Table 4). Strikingly, 
these larger pockets are lined by the structural 
equivalents of most of the residues that line 
the SidNA3 pocket plus some additional 
residues. The additional size of the LCFA 
pocket is unsurprising as it binds and activates 
myristate and palmitate, substrates which are 
larger than that of SidNA3. The larger size of 
the luciferase binding pocket in comparison to 
that of SidNA3 is somewhat surprising as the 
substrate, luciferin, is similar in size to cis-
AMHO. However, most of the extra binding-
pocket residues seen, in addition to those in 
SidNA3, do not appear to be in contact with 
the luciferin ligand; rather, they play a 
catalytic role (47). The remaining fourteen 
structures have similar-sized or smaller 
binding pockets than SidNA3 (Table 4) and 
the pockets of these enzymes are mainly lined 
by a subset of residues equivalent to those in 
SidNA3. The binding pocket of SidNA3 
defines the upper limits of NRPS adenylation 
domain binding pockets, as cis-AMHO is one 
of the largest amino acids to be incorporated 
into secondary metabolites by NRPSs.  
 
DISCUSSION 
 
We have determined the structure of SidNA3, 
the first structure of a eukaryotic NRPS 
domain. Activity assays clearly show that 
SidNA3 adenylates cis-AMHO but not any of 
the 20 proteogenic amino acids or L-ornithine. 
This is the first experimental evidence in 
support of the predictions that the third 
module of three-module siderophore 
sythetases adenylate AHO residues (13,18). 
Consistent with it binding cis-AMHO, one of 
the largest substrates of the acetyl-CoA 
synthetase-like superfamily, the amino acid 
binding pocket of SidNA3 is much larger than 
that of PheA (9). The SidNA3 binding pocket 
is lined by seventeen rather than nine residues 
(as seen for PheA), and defines the upper 
limits of NPRS adenylation domain binding 
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pockets. Previous homology modeling 
predicted that the AHO-activating domains 
would have larger pockets than PheA (13,18), 
but do not correctly identify all of the residues 
involved in substrate binding. This highlights 
the value of an experimentally determined 
structure in understanding substrate specificity 
for the large family of eukaryotic NRPS 
enzymes.  
 
The N- and C-terminal domains in the SidNA3 
structure are arranged in an open conformation 
previously unseen in NRPS adenylation 
domains. This conformation is distinct from 
the two catalytically active conformations 
thought to be adopted by members of the 
acetyl-CoA synthetase-like superfamily (7). 
However, similar open conformations have 
previously been observed in four other 
members of the superfamily (PDB codes 1lci 
(42), 1ult (43), 2vsq (17), and 3g7s). The exact 
orientation of the C-terminal domain relative 
to the N-terminal domain is different in each 
of these structures. Nevertheless, the structures 
are similar in that there is a wide separation 
between the two domains and a highly 
accessible active site. Given the lack of 
interactions between the two domains in the 
open conformation, it is likely that the exact 
orientation of the C-terminal domain seen in 
these structures is stabilized by crystal packing 
and that the C-terminal domain is mobile in 
solution. This is supported by the high 
mobility of the C-terminal domains observed 
in the SidNA3 structure. Furthermore, in the 
structure of the open conformation of the long-
chain fatty acyl-CoA synthetase (43), the 
C-terminal domain of each monomer of the 
enzyme, which forms a domain-swapped 
dimer, is in a different “open” orientation (43).  
 
The recent structure of the surfactin synthetase 
termination module (SrfAC) from Bacillus 
subtilis (17) has provided further insights into 
the relevance of the open conformations for 
NRPS adenylation domains. This structure 
shows that the condensation domain and the 
N-terminal part of the adenylation domain 
associate closely to form a catalytic platform. 
The PCP domain and the C-terminal part of 
the adenylation domain rearrange on this 
platform to move the tethered peptide product 
between the reaction centers (17). It seems 
probable that the conformational changes of 
the adenylation domain would be coordinated 
with rearrangements in the positioning and 
conformation of the PCP domain. This is 
further reinforced by the fact that the 4’ppant 
arm in SrfAC is not long enough to reach each 
of the catalytic centers, implying considerable 
mobility amongst the domains of NRPSs. 
Thus, in addition to the adenylation and 
thiolation conformations, the adenylation 
domain may also adopt at least two other 
stable conformations that allow the PCP 
domain and 4’ppant to be positioned in the 
reaction centers of the preceding and 
successive domains in the peptide synthesis 
reaction pathway. In the SrfAC structure, the 
PCP domain is positioned such that the 
4’ppant arm would be able to reach into the 
active site of the preceding condensation 
domain, suggesting that the module is in a 
conformation suitable for catalyzing the 
condensation reaction (17). The adenylation 
domain is in an open conformation with the 
C-terminal domain stabilized by interactions 
with the neighboring condensation domain 
(17). SidNA3 was crystallized in isolation 
from its neighboring domains and, hence, 
cannot form similar interactions, which would 
explain the high mobility of the C-terminal 
domain.  
 
The residues lining the substrate-binding 
pocket of PheA (9) have previously been used 
to develop methods to predict the specificities 
of newly identified adenylation domains (10-
12). The specificity of a novel adenylation 
domain is predicted based on its similarity to 
the signature sequences of adenylation 
domains with known substrates. These 
methods work well for prokaryotic NRPSs but 
are generally unsuccessful for eukaryotic 
NRPSs (13). Of significant interest is whether 
the SidNA3 binding pocket is able to 
discriminate between acyl-hydroxyornithines 
with the various acyl groups seen in 
siderophores (Fig. 6). In silico ligand docking 
of AHOs into the SidNA3 structure was 
undertaken and showed cis-AMHO as the top-
ranked substrate, consistent with the fact that 
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it is the in vivo substrate. Visualization of the 
in silico-bound cis-AMHO shows that the 
terminal alcohol of the ligand is hydrogen 
bonded to the sidechain hydroxyl of Tyr293. 
Tyr293 is one of the few hydrogen bonding 
partners in the SidNA3 binding pocket and is 
located at the very base of the pocket, which is 
otherwise a largely hydrophobic site. 
Furthermore, comparisons of the pocket-lining 
residues of other AHO- adenylating domains 
showed that the SidNA3 domain clustered 
with those known to activate cis-AMHO 
(Table 3). The discrimination in the AHO that 
are used to synthesize the siderophore in vivo 
may also be due to limitations in the pool of 
AHOs available in the cell. Further 
experimental investigation is necessary to 
resolve the questions of the specificity of the 
SidNA3 domain for AHO residues. 
Nevertheless, our results demonstrate the 
specificity of SidNA3 for AHOs over 
ornithine or any of the other 20 common 
amino acids.  
 
The structure of SidNA3 shows that although 
the substrate-binding pockets of eukaryotic 
NRPS adenylation domains are constructed 
along fundamentally similar principles to their 
prokaryotic counterparts, their elaboration to 
accommodate more complex substrates is not 
readily predictable from sequence comparison 
alone. The low success rate of specificity-
prediction methods for eukaryotic domains is 
due to the divergence in their signature 
sequences from those of prokaryotes. The 
structure of SidNA3 therefore provides a 
springboard for the development of more 
accurate specificity prediction methods for the 
abundant eukaryotic NRPS adenylation 
domains.  
 
It is possible that eukaryotes utilize a more 
diverse set of signature sequences than the 
prokaryotes. Furthermore, it is perhaps rather 
simplistic to attempt prediction of NRPS 
substrate specificities using just the nine 
residues that line the PheA pocket. It is 
obvious from the comparisons of the substrate 
binding pockets of superfamily members that 
the size of the pocket varies considerably. By 
limiting the comparisons to the nine PheA 
residues, some of the important specificity-
determining residues may be missed, 
especially for larger substrates. Expanding the 
number of residues considered to match those 
found in the SidNA3 pocket will serve to 
improve the coverage of the possible 
specificity-determining residues. This would 
be at the expense of increasing the noise for 
smaller pockets, however, and the pocket size 
itself is probably a key specificity determinant 
for many of these enzymes. Thus, it is likely 
that the greater use of structurally-based tools 
such as homology modeling based on 
appropriate templates, employed to inform 
comparisons of the unknown domains with 
those of known specificity, will prove more 
fruitful than simple sequence comparisons. 
Development of an accurate substrate 
prediction method for domains of unknown 
specificity is now the subject of current work.  
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FIGURE LEGENDS 
 
FIGURE 1. SidNA3 activity assays. Indicative plots of the accumulation of PPi, as monitored by 
absorbance at 360nm, for SidNA3 activity using the 20 proteogenic amino acids, 
Nδ-cis-anhydromevalonyl-Nδ-hydroxy-ornithine (cis-AMHO), and ornithine (Orn) as substrates. 
The assay was conducted three times using different concentrations of enzyme and substrate. In 
each case cis-AMHO was the only amino acid which was adenylated. Subsequently, duplicate 
assays were conducted to calculate observed kcat and Km values (see text for details).  
 
FIGURE 2. The structure and topology of SidNA3. A, Ribbon diagram of the SidNA3 
structure. The N-terminal domain is made up of a distorted six-stranded antiparallel β-barrel (red) 
together with an αβαβα structure formed by two predominantly parallel β-sheets flanked by α-
helices (blue and purple). The C-terminal domain (orange) is made up of a three-stranded 
antiparallel β-sheet surrounded by three α-helices. A long loop in the C-terminal domain, located 
between the final β-strand and the final α-helix, loops back towards the N-terminal domain and is 
marked. B, Topology diagram of SidNA3. Drawn in the same style as that of the PheA topology 
diagram in Conti et al. (9) and using the same numbering scheme for the β-strands. The circles 
represent α-helices and the arrows β-strands. The locations of the chain breaks (due to poor 
electron density) in the SidNA3 model are marked. 
 
FIGURE 3. Structure-based sequence alignment. Structure-based sequence alignment of the 
protein sequences SidNA3 (top) and PheA (9) (bottom). The position of the β-strands and α-
helices for both structures are shown. The numbering scheme for the β-strands is that used in 
Conti et al. (9). The residues not present in the models are indicated by lower-case letters and the 
first five N-terminal residues of SidNA3, which are cloning artifacts, are shown in grey lettering 
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and given negative numbers. The residues involved in binding the amino acid substrate are 
shaded (dark grey for the standard PheA residues and light grey for the extra SidNA3 residues). 
 
FIGURE 4. The orientation of the C-terminal domain for SidNA3. A, Stereo ribbon diagram 
showing the orientation of the C-terminal domain in SidNA3 compared to the adenylation 
conformation of PheA (9). The C-terminal domain of SidNA3 is red and that of PheA is blue. The 
N-terminal domains have been aligned and are shown in grey. The second α-helix and subsequent 
β-strand of the C-terminal domains are colored in lighter shades to aid visualization of the 
rotation between the conformations. B, Molecular surface diagram showing the accessibility of 
the active sites in the open conformation of SidNA3 compared to the adenylation conformation of 
PheA (9). The amino acid-binding pocket is shown in red and the C-terminal domain is colored 
blue. 
 
FIGURE 5. The amino acid binding pocket of SidNA3. A, Stereo “Connolly” surface (48) 
diagram of the amino-acid binding pocket of SidNA3 and the residues lining it. The entrance to 
the pocket is to the left of the diagram. B, Stereo diagram comparing the residues lining the 
amino-acid binding pockets of SidNA3 and PheA (9). The SidNA3 residues are pink and the 
PheA residues are blue. The residues of PheA are labeled in blue italics. C, Stereo diagram 
comparing residues involved in binding the main-chain atoms of the amino acid ligand in SidNA3 
and PheA (9). The SidNA3 residues are pink, the PheA residues are blue and the phenylalanine 
ligand of PheA is green. The C-terminal domain loops of both molecules are also shown. The 
only binding pocket-lining residues shown are those of PheA. The hydrogen bonds between PheA 
and the phenylalanine ligand are shown. D, Stereo diagram of cis-AMHO docked into the binding 
pocket of SidNA3. The SidNA3 residues lining the binding pocket are pink. The top-ranked 
solution for the docking of the cis-AMHO ligand is shown in dark blue. The hydrogen bonds 
between SidNA3 and the docked ligand are shown (a hydrogen bond between the ligand’s 
α-amino group and Asp231 is hidden behind the ligand).  
 
FIGURE 6. Nδ-acyl-Nδ-hydroxy-L-ornithine amino acids found in fungal hydroxamate 
siderophores. The various R groups are shown below the parent at the top of the figure.  
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TABLES 
 
TABLE 1 
X-ray data and refinement statistics 
Data collection 
Data set High-resolution MAD 
Space group P1 P1 
Cell dimensions    
a, b, c (Å) 50.6, 75.3,84.1 50.7, 75.6, 84.3 
α, β, γ (°) 114.9, 94.8, 90.2 115.1,94.9,90.3 
  Peak Inflection Remote 
Wavelength 0.97939 0.97939 0.97951 0.91162 
Resolution (Å)a 43.9-2.00    
(2.1-2.00) 
50.4-2.55 
(2.69-2.55) 
50.4-2.55 
(2.69-2.55) 
50.4-2.37 
(2.50-2.37) 
Completeness (%)a 96.2 (95.0) 97.4 (95.9) 97.4 (95.6) 97.3 (95.6) 
Average I/σIa 13.2 (3.0) 14.8 (3.9) 14.8 (3.7) 12.0 (2.4) 
Unique reflectionsa 72902 (10538)  35814 (5178)  35817 (5179)  44562 (6393) 
Redundancya 3.7 (3.7) 3.8 (3.8) 3.8 (3.8) 3.8 (3.8) 
Rsym(%)a, b 8.4 (55.9) 6.8 (28.8) 6.9 (30.2) 8.5 (46.9) 
Refinement  
Resolution range (Å) 42.6-2.0 
Number of reflections 72482 
Number of atoms  
Protein 6930 
Ligand/ions 12 
Water 455 
R Factorc 0.194 
Rfreed 0.228 
Wilson B factor 
Average B factors (Å2) 
24.5 
Protein 37.0 
N-term. A 30.7 
N-term. B 33.6 
C-term. B 76.4 
Ligand/ions 39.8 
Water 39.9 
R.m.s. deviations  
Bond lengths (Å) 0.018 
Bond angles (°) 1.645 
Ramachandran 
analysis (%)e 
 
Most favored 96.2 
Additionally allowed 3.6 
Outliers 0.2 
a Data in parentheses are for the outermost data shell. 
b Rsym = ∑h∑j|I(h;j) – ∑(h)|/∑h∑jI(h), where I(h;j) is the jth measurement of the intensity of the 
unique reflection h, and Î(h) is the mean over all symmetry-related measurements. 
c R factor = ∑|Fobs – Fcalc|/Fobs, where Fobs and Fcalc are the observed and calculated structure-
factor amplitudes, respectively.  
d Rfree is the R factor of the 5% of data (selected randomly) not used in refinement. 
e According to the definitions of Lovell et al. (49). 
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TABLE 2 
Ligands ranked according to in silico docking using GOLD  
Rank Ligand Score 
1 Nδ-cis-anhydromevalonyl-Nδ-hydroxy-L-ornithine 22.35 
2 Nδ-cis-anhydromevalonyl-Nδ-hydroxy-D-ornithine 21.64 
3 Nδ-trans-anhydromevalonyl-Nδ-hydroxy-L-ornithine 20.98 
4 Nδ-trans-anhydromevalonyl-Nδ-hydroxy-D-ornithine 20.31 
5 Nδ-cis-β-methylglutaconyl-Nδ-hydroxy-L-ornithine 19.95 
6 Nδ-cis-5-acetoxy-3-methylpent-2-enoyl-Nδ-hydroxy-L-ornithine 19.05 
7 Nδ-cis-β-methylglutaconyl-Nδ-hydroxy-D-ornithine 19.03 
8 Nδ-(S)-mevalonyl-Nδ-hydroxy-L-ornithine 18.68 
9 Nδ-(R)-β-hydroxybutyryl-Nδ-hydroxy-L-ornithine 18.09 
10 Nδ-(S)-trans-4,5-dihydroxy-3-methyl-2-pentenoyl-Nδ-hydroxy-L-ornithine 18.03 
 
TABLE 3 
Amino-acid residues lining the binding pockets of Nδ-acyl-Nδ-hydroxy-ornithine-activating 
adenylation domains  
NRPS Domain Predicted acyl group Binding pocket Species Accession  
SidN A3 anhydromevalonyl FWIFVGELGYGGVIG	   Neotyphodium lolii  
SidD A1 cis-anhydromevalonyl SRVVVDSLGGGGGIG	   Aspergillus fumigatus XP_748662 
Nps6 A1 cis-anhydromevalonyl SRISVDSCNSGGGIG	   Gibberella zeae XP_383923 
Nps6 A1 cis-anhydromevalonyl GRVVVDSCGSAGAVG	   Alternaria brassicicola ABI51983 
Nps6 A1 cis-anhydromevalonyla GRVCVDCCHVGGAVG	   Neurospora crassa XP_963411 
Fso1 A3 trans-β-methylglutaconyl MFVFIIEAFCITALG	   Omphalotus olearis AAX49356 
SidFA A3 trans-β-methylglutaconyla FYVYVSQMSFGGAIM	   Ustilago maydis XP_757581 
Nps1 A3 malonyla FFLYPTQVGVTGFIG	   Gibberella zeae XP_391202 
Nps2 A3 acetyla LFFWVLEWDVIGFIG	   Aureobasidium pullulans AAD00581 
Nps2 A3 acetyla CFFWVLEWDVIGFIG	   Neurospora crassa EAA31066 
Nps2 A3 acetyl AFFWVLEWDVIGAIG	   Gibberella zeae XP_385548 
Sib1 A3 acetyl CFFFVLEFDVIGFIG	   S. pombe NP_593102 
Sid2 A3 acetyl AWLFVIEMDWMGAIG	   Ustilago maydis O43103 
SidC A3 acetyla FFVYVLEFSYSGAIG	   Aspergillus fumigatus EAL91050 
SidC A3 acetyl FIAYPLEFSFTGAIG	   Aspergillus nidulans AAP56239 
a Predicted but experimentally unconfirmed 
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TABLE 4 
The pocket-lining residues in the acetyl-CoA synthetase-like superfamily 
PheA res 210 211 213 214 215 216 217 218 220 226 230 235 
LCFA H204 S205  A208 S209   T214 L216  V226 V231 
Luci R220   A224  Y229a G230 N231    G248 
SidNA3 F198   W202    I206  F222  D231 
FAL    I208    I213 L215 C221  D230 
FadD1            S231 
PheA            D235 
ACSM2A            I266 
CBAL   F184         V208 
SrfAC            D659 
DhbE            N235 
BCL            A237 
DltA            D197 
AAE        W237    G255 
ACS            V310 
FAAL28b            D222 
 
PheA res 236 237 239 240 243 244 247 276 277 278 297 299 
LCFA W234c A233a C235 L236 A239   F270  A272  V299 
Luci F249  F252 T253 G256 Y257 C260 S286 V287a I288 E313 A315 
SidNA3 V232  G235 E236 L239     G272 Y293 G295 
FAL M231  G235 F236 T239   V273  V275  G305 
FadD1 A232  G235 L236    F269  W271  A300 
PheA A236  W239       T278  I299 
ACSM2A L267  L270 C271      M309   
CBAL V209         F249   
SrfAC A660         F702   
DhbE Y236  S240          
BCL Y238            
DltA L198            
AAE K256  W259          
ACS T311            
FAAL28b M223            
 
PheA res 300 301 320 321 322 323 324 325 326 330 331 334 335 
LCFA V300a G301   G323  G325   P331 V332 Q335  
Luci S316a A317 R339 Q340a G341  G343   S349 A350 I353 T354 
SidNA3 V296a G297   V320  G322   I328 G329   
FAL  G307 M334  C336  G338   L344 A345 F348  
FadD1 T301a G302   I332  G334   P340 M341   
PheA  A301   A322  G324   I330 C331   
ACSM2A  V337     G362   G367 L368   
CBAL  A280   I303  G305   M310 N311   
SrfAC  G728   C752  G754   V760 F761   
DhbE  G306   V329  G331    V337   
BCL  A308     G333   H339 I340   
DltA  C269     G295   V301 A302   
AAE  A326   G349a F350a G351a Q352a T353     
ACS  V386     W414       
FAAL28b  V442     G330   V336    
aOnly the main-chain atoms of these residues line the pocket. 
bThe binding pocket exposed to solvent in the FAAL28 structure, which was solved in un-
liganded form, is too small to accommodate its long-chain fatty acid substrate. There is an 
internal cavity in the protein closed off by M233. M233 is the equivalent of the W234 residue in 
LCFA which closes off the entrance to the binding pocket in the unliganded form and opens up 
upon ATP binding. Thus, it is likely that M233 in FAAL28 is performing a similar function and 
that the true binding pocket is much larger. 
cIn LCFA, sequence alignments place N232 as the equivalent of the PheA residue 236 but 
structural comparisons show that it is actually W234 that is the structurally equivalent residue due 
to an alternate main-chain route. 
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The dark grey shading denotes the PheA pocket-lining residues and while light grey shading 
denotes the extra SidNA3 pocket-lining residues. The structures are LCFA (1v26), Thermus 
thermophilus long-chain fatty acyl-CoA synthetase (43); Luci (2d1s), Japanese firefly Luciola 
cruciata luciferase (47); SidNA3 (this work), Neotyphodium lolii third adenylation domain from 
SidN; FAL (3gqw), Escherichia coli fatty-acid-AMP ligase; FadD1 (3g7s), Archaeoglobus 
fulgidus long-chain-fatty-acid-CoA ligase; PheA (1amu), Bacillus brevis adenylation domain 
from gramicidin S synthetase A (9); ACSM2A (3eq6), Homo sapiens medium-chain acyl-CoA 
synthetase (50); CBAL (1t5d), Alcaligenes sp. AL3007 4-chlorobenzoyl-CoA ligase (51); SrfAC 
(2vsq), Bacillus subtilis adenylation domain from surfactin synthetase C (17); DhbE (1md9), B. 
subtilis DhbE adenylation domain (16); BCL (2v7b), Burkholderia xenovorans benzoate-CoA 
ligase (52); DltA (3dhv), Bacillus cereus D-alanyl-carrier protein ligase (53); AAE (3etc), 
Methanosarcina acetivorans acyl-CoA synthetase (54); ACS (1pg4), Salmonella enterica acetyl-
CoA synthetase (7); and FAAL28 (3e53), Mycobacterium tuberculosis fatty acyl-AMP ligase 28 
N-terminal domain (55). The American firefly Photinus pyralis luciferase (42,56), B. subtilis D-
alanyl-carrier protein ligase (6), and the Salmonella typhimurium (57) and Saccharomyces 
cerevisiae (58) acetyl-CoA synthetases are not included in the table due to the high similarity of 
their binding sites to the homologous structures that are included. 
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